Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
Precision PCR for Cervical Cancer Elimination
06 Jan 2026 -
50 Years of Culturing Innovation
05 Jan 2026
MICROBIOLOGY EVENTS
-
10th Anniversary Microbiome Movement Summit
27 Jan 2026 -
Redefining Bacillus cereus Testing: An Innovative Solution for Today’s Challenges
28 Jan 2026 -
WHX Labs Dubai
9 Feb 2026 -
World Water-tech Innovation Summit
24 Feb 2026 -
4th International Beverages Quality Conference 2026
3 Mar 2026 -
Forum LABO 2026
10 Mar 2026 -
2026 QC Micro Summit
17 Mar 2026 -
Advanced Therapies
17 Mar 2026 -
ISPE Aseptic Conference 2026
23 Mar 2026 -
Analytica 2026
24 Mar 2026